We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » POSTMARKETING COMMITMENTS, MEDICARE Rx CARDS PART OF HHS OIG'S WORK PLAN
POSTMARKETING COMMITMENTS, MEDICARE Rx CARDS PART OF HHS OIG'S WORK PLAN
October 22, 2004
Evaluating how drug firms compute the average sales price (ASP) for drugs reimbursed under Medicare and determining the extent to which the FDA monitors drugmakers' postmarketing study commitments are among the investigations HHS' Office of Inspector General (OIG) plans to undertake in fiscal 2005.